Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
63.05
-0.55 (-0.86%)
Sep 10, 2025, 1:44 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 12.65 billion as of September 9, 2025.
Market Cap
12.65B
Enterprise Value
12.48B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
63.05
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has decreased from 12.97B to 12.65B, a decrease of -2.51%. That is a compound annual growth rate of -18.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 9, 2025 | 12.65B | -2.97% |
Sep 8, 2025 | 13.04B | -0.38% |
Sep 5, 2025 | 13.09B | 8.76% |
Sep 4, 2025 | 12.03B | -2.34% |
Sep 3, 2025 | 12.32B | -2.44% |
Sep 2, 2025 | 12.63B | -4.94% |
Sep 1, 2025 | 13.29B | 1.06% |
Aug 29, 2025 | 13.15B | 11.28% |
Aug 28, 2025 | 11.81B | -9.24% |
Aug 27, 2025 | 13.02B | -0.83% |
Aug 26, 2025 | 13.13B | -2.94% |
Aug 25, 2025 | 13.52B | 0.97% |
Aug 22, 2025 | 13.40B | -3.79% |
Aug 21, 2025 | 13.92B | -0.43% |
Aug 20, 2025 | 13.98B | -4.29% |
Aug 19, 2025 | 14.61B | -2.20% |
Aug 18, 2025 | 14.94B | 8.29% |
Aug 15, 2025 | 13.79B | 5.24% |
Aug 14, 2025 | 13.11B | -3.94% |
Aug 13, 2025 | 13.64B | 0.37% |
Aug 12, 2025 | 13.59B | 2.78% |
Aug 11, 2025 | 13.23B | -3.27% |
Aug 8, 2025 | 13.67B | -2.83% |
Aug 7, 2025 | 14.07B | -1.67% |
Aug 6, 2025 | 14.31B | -1.26% |
Aug 5, 2025 | 14.49B | 4.83% |
Aug 4, 2025 | 13.83B | 2.14% |
Aug 1, 2025 | 13.54B | -2.98% |
Jul 31, 2025 | 13.95B | -5.87% |
Jul 30, 2025 | 14.82B | -1.48% |
Jul 29, 2025 | 15.04B | 6.14% |
Jul 28, 2025 | 14.17B | 9.24% |
Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 297.05B |
Hansoh Pharmaceutical Group Company | 231.38B |
JD Health International | 201.85B |
Innovent Biologics | 172.13B |
Sino Biopharmaceutical | 161.14B |
WuXi Biologics | 158.17B |
Akeso | 131.26B |
CSPC Pharmaceutical Group | 131.25B |